-+ 0.00%
-+ 0.00%
-+ 0.00%

Immix Biopharma CFO and President Gabriel Morris Reports $10,011.08 Common Share Acquisition

PUBT·11/20/2026 13:48:02
Immix Biopharma CFO and President Gabriel Morris Reports $10,011.08 Common Share Acquisition
  • Immix Biopharma CFO, President and director Gabriel S. Morris purchased 1,418 common shares at $7.06 each.
  • His direct common stock holdings rose to 292,847 shares.
  • Separately reported indirect common stock holdings were 426,844 shares and 24,141 shares.


Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Immix Biopharma Inc. published the original content used to generate this news brief via EDGAR, the Electronic Data Gathering, Analysis, and Retrieval system operated by the U.S. Securities and Exchange Commission (Ref. ID: 0001493152-26-053369), on November 20, 2026, and is solely responsible for the information contained therein.